F. Janku, “Efficacy of weekly trastuzumab and paclitaxel in the treatment of women with HER-2/neu overexpressing metastatic breast cancer. The impact of taxane free interval on treatment outcomes”, Radiol Oncol, vol. 36, no. 2, Jun. 2002.